Biote CORP 10-Q quarterly reports

Biote Corp. reported a significant decrease in revenue and net income for Q1 2026, impacted by a product recall, increased legal expenses, and a shift in revenue streams.

Biote Corp. reported a significant swing to net income for the nine months ended September 30, 2025, despite a decline in total revenue for both the quarter and year-to-date periods.

Biote Corp. reported a significant shift from net losses to net income and increased Adjusted EBITDA, driven by cost efficiencies and strategic supply chain management, despite a decline in core pellet procedure revenue.

biote Corp. reports a revenue increase and a return to net income profitability for Q1 2025, while navigating legal challenges and a CEO transition.

Biote Corp. announced its third quarter 2024 results, highlighting a 12.8% increase in revenue compared to the same period last year, driven by growth in product and service revenue.

Biote Corp. released its second quarter 2024 results, highlighting revenue growth in pellet procedures, offset by a decline in dietary supplement sales, and significant expenses related to legal settlements and acquisitions.

Biote Corp. announced its first quarter 2024 results, showing a modest revenue increase and a net loss, while also detailing a significant legal settlement with its founder.